PLACIDYL Drug Patent Profile
✉ Email this page to a colleague
When do Placidyl patents expire, and when can generic versions of Placidyl launch?
Placidyl is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in PLACIDYL is ethchlorvynol. There is one drug master file entry for this compound. Additional details are available on the ethchlorvynol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PLACIDYL?
- What are the global sales for PLACIDYL?
- What is Average Wholesale Price for PLACIDYL?
Summary for PLACIDYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 17 |
| Patent Applications: | 1,931 |
| DailyMed Link: | PLACIDYL at DailyMed |
US Patents and Regulatory Information for PLACIDYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | PLACIDYL | ethchlorvynol | CAPSULE;ORAL | 010021-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | PLACIDYL | ethchlorvynol | CAPSULE;ORAL | 010021-010 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | PLACIDYL | ethchlorvynol | CAPSULE;ORAL | 010021-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | PLACIDYL | ethchlorvynol | CAPSULE;ORAL | 010021-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
